Stockreport

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com
PDF Belbuca Revenue: $53.2 million, up 17% year-over-year. Xtampza ER Revenue: $49.5 million, up 24% year-over-year. Nucynta Franchise Revenue: $45.1 million, down 5% y [Read more]